Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats

Toxicology and Applied Pharmacology

Volumn 205, Issue 1, 2005, Pages 43-52

  Mahgoub, Afaf ^a   El Medany, Azza ^a   Mustafa, Ali ^a   Arafah, Maha ^b   Moursi, Mahmoud ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c MINISTRY OF HEALTH   (Saudi Arabia)

Author keywords

Azithromycin; Erythromycin; Myeloperoxidase; Nitric oxide synthetase; Tumour necrosis factor alpha; Ulcerative colitis

Indexed keywords

ACETIC ACID; AZITHROMYCIN; ERYTHROMYCIN; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COLON INJURY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; EDEMA; ENZYME ACTIVITY; HISTOLOGY; INFLAMMATION; MALE; MEASUREMENT; NECROSIS; NONHUMAN; RAT; ULCERATIVE COLITIS;

ACETIC ACID; ANIMALS; AZITHROMYCIN; COLITIS, ULCERATIVE; COLON; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ERYTHROMYCIN; INTERFERON TYPE II; MALE; NITRIC OXIDE SYNTHASE; PEROXIDASE; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18844400561     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.09.012     Document Type: Article

References (62)

1. J.S. Beckman, T.W. Beckman, J. Chen, P.A. Marshall, and B.A. Freeman Apparent hydroxyl radical production by peroxynitrite: implications for endothelial cell injury from nitric oxide and superoxide Proc. Natl. Acad. Sci. U.S.A. 87 1990 1620 1624
2. N.K. Boughton-Smith, S.M. Evans, B.J.R. Whittle, and S. Moncada Induction of colonic nitric oxide synthase in a rat model of colitis Gastroenterology 102 1992 A598
3. N.K. Boughton-Smith, S.M. Evans, C.J. Hawkey, A.T. Cole, M. Balsitis, B.J.R. Whittle, and S. Moncada Nitric oxide synthase activity in ulcerative colitis and Crohn's disease Lancet 342 1993 338 340
4. M.M. Bradford A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anan. Biochem. 72 1976 248 254
5. P.D. Bradley, D.A. Friebal, and R.D. Christensen Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker J. Invest. Dermatol. 78 1982 206 209
6. D.A. Burke, and A.T.R. Axon Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea BMJ 297 1988 102 107
7. M. Chiesi, and R. Schwaller Inhibition of constitutive endothelial NO-synthase activity by tannin and quercetin Biochem. Pharmacol. 49 1995 195 501
8. N.V. Contractor, H. Bassiri, T. Reya, A.Y. Park, D.C. Baumgart, M.A. Wasik, S.G. Emerson, and S.R. Carding Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnobiotic IL-2 deficient mice J. Immunol. 160 1998 385 394
9. B. Derkz, J. Taminiau, S. Radema, A. Sronkhorst, C. Wortel, G. Tytgat, and S. Van Deventer Tumour-necrosis factor antibody treatment in Crohn's disease Lancet 342 1993 173 174
10. L. Dianda, A.M. Hanby, N.A. Wright, A. Sebesteny, A.C. Hayday, and M.J. Owen T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment Am. J. Pathol. 150 1997 91 97
11. R. Duchmann, I. Kaiser, E. Hermann, W. Mayet, K. Ewe, and K.H. Meyer Zum Buschenfelde Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) Clin. Exp. Immunol. 102 1995 448 455
12. C.O. Elson, Y. Cong, N. Iqbal, and T. Weaver Immuno-bacterial homeostasis in the gut: new insights into an old enigma Semin. Immunol. 13 2001 187
13. R.J. Farrell, and J.T. LaMont Microbial factors in inflammatory bowel disease Gastroenterol. Clin. North Am. 34 2002 41 62
14. M. Fukuda, O. Kanauchi, Y. Arak, A. Andoh, K. Mitsuyama, K. Takagi, A. Toyonaga, M. Sata, Y. Fujiyama, M. Fukuoka, Y. Matsumato, and T. Bamba Prebiotic treatment of experimental colitis with germinated barley food stuff: a comparison with probiotic treatment Int. J. Mol. Med. 9 2002 65 70
15. J. Galvez, M. Garrido, M. Merlos, M.I. Torres, and A. Zarzuelo Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat Br. J. Pharmacol. 130 2000 1949 1959
16. K.R. Gardiner, N.H. Anderson, M.D. McCaigue, P.J. Erwin, M.I. Halliday, and B.J. Rowlands Enteral and parenteral anti-endotoxin treatment in experimental colitis Hepato-Gastroenterology 41 1994 554 558
17. W. Hans, J. Scholmerich, V. Gross, and W. Falk The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice Eur. J. Gastroenterol. Hepatol. 12 2000 267 273
18. M.L. Harris, H.J. Schiller, P.M. Reilly, M. Donowitz, M.B. Grisham, and G.B. Bulkley Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon? Pharmacol. Ther. 53 1992 375 408
19. C.M. Hogaboam, K. Jacobson, S.M. Collins, and M.G. Blennerhassett The selective beneficial effects of nitric oxide inhibition in experimental colitis Am. J. Physiol. 268 1995 G673 G684
20. H.C. Jung, L. Eckmann, S.K. Yang, A. Panja, J. Fierer, E. Moryzcka-Wroblewska, and M.F. Kagnoff A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion J. Clin. Invest. 95 1995 55 65
21. H. Kimura, S. Miura, T. Shigematsu, N. Ohkubo, Y. Tsuzuki, I. Kurose, H. Higuchi, Y. Akiba, R. Hokari, M. Hirokawa, H. Serizawa, and H. Ishii Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease Dig. Dis. Sci. 42 1997 1047 1054
22. I.S. Klasen, M.J. Melief, and A.G.S. Van Halteren The presence of peptidoglycan-polysaccharide complexes in the bowel wall and the cellular responses to these complexes in Crohn's disease Clin. Immunol. Immunopathol. 71 1994 303 308
23. G. Kojouharoff, W. Hans, F. Obermeier, D.N. Mannel, T. Andus, J. Scholmerich, V. Gross, and W. Falk Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice Clin. Exp. Immunol. 107 1997 353 358
24. R.K. Linskens, X.W. Huijsdens, P.H.M. Savelkoul, C.M.J.E. Vandenbroucke-Grauls, and S.G.M. Meuwissen The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics Scand. J. Gastroenterol. 234 2001 29 40
25. C. Loguercio, G. D'Argenio, M. Delle Cave, V. Gosenza, N. Della Valle, G. Mazzacco, and C. del Vecchio Blanco Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats Dig. Dis. Sci. 41 1996 1204 1211
26. R.P. MacDermott Alterations of the mucosal immune system in inflammatory bowel disease J. Gastroenterol. 31 1996 907 916
27. T.T. MacDonald, P. Hutchings, M.J. Choy, S. Murch, and A. Cooke Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine Clin. Exp. Immuno. 81 1990 301 305
28. S.A. McDonald, M.J. Palmen, E.P. Van Rees, and S.A. MacDonald Characterization of the mucosal cell mediated immune response in IL-2 knockout mice before and after the onset of colitis Immunology 91 1997 73 80
29. K.L. Madsen, J.S. Doyle, M.M. Tavernini, L.D. Jewell, R.F. Rennie, and R.N. Fedorak Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice Gastroenterology 118 2000 1094 1105
30. R.A. Maini, F.M. Brennen, R. Williams, C.Q. Chu, A.P. Cope, and D. Gibbons TNFα in rheumatoid arthritis and prospects of anti-TNF therapy Clin. Exp. Rheumatoid 11 1993 S173 S175
31. M.J.S. Millar, H. Sadowska-Krowicka, S. Chotinaruemol, J.L. Kakkis, and D.A. Clark Amelioration of chronic ileitis by nitric oxide synthase inhibition J. Pharmacol. Exp. Ther. 264 1993 11 16
32. A.D. Millar, D.S. Rampton, C.L. Chander, A.W.D. Claxson, S. Blades, A. Coumbe, J. Panetta, C.J. Marris, and D. Blake Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis Gut 39 1996 407 415
33. S. Moncada, R.M.J. Palmer, and E.A. Higg Nitric oxide: physiology, pathophysiology and pharmacology Pharmacol. Rev. 43 1991 109 142
34. A.B. Onderdonk Intestinal microflora and inflammatory bowel disease J.B. Kirsner Inflammatory Bowel Disease 5th ed. 2000 W.B. Saunders Philadelphia, PA 144 152
35. A.B. Onderdonk, J.A. Hermos, J.L. Dzink, and J.G. Bartlett Protective effect of metronidazole in experimental ulcerative colitis Gastroenterology 74 1978 521 526
36. C.M. Panwala, J.C. Jones, and J.L. Vincy A novel model of IBD: mice deficient for the multiple drug resistant gene, mdr la, spontaneously develop colitis J. Immunol. 161 1998 5733
37. + T cells Immunity 1 1994 553 562
38. D. Rachmilewitz, J.S. Stamler, F. Karmeli, M.E. Mullins, D.J. Singel, J. Loscalzo, R.J. Xavier, and D.K. Podolsky Peroxynitrite-induced rat colitis-a new model of colonic inflammation Gastroenterology 105 1993 1681 1688
39. D. Rachmilewitz, J.S. Stamler, and D. Bachwich Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease Gut 36 1995 718 723
40. 2 microglobulin transgenic rats J. Clin. Invest. 98 1996 945 953
41. H.C. Rath, M. Schultz, R. Freitag, L.A. Dieleman, F. Li, H.J. Linde, J. Scholmerich, and B. Sartor Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice Infect. Immun. 69 2001 2277 2285
42. J.M. Reimund, C. Wittersheim, S. Dumont, C.D. Muller, J.S. Kenney, R. Baumann, P. Poindron, and B. Duclos Increased production of tumour necrosis factor-alpha interleukin-1 beta and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease Gut 39 1996 684 689
43. H.C. Reinecker, M. Steffen, T. Witthoeft, I. Pflueger, S. Schreibe, R.P. MacDermatt, and A. Raedler Enhanced secretion of tumour necrosis factor-alpha, IL-6 and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease Clin. Exp. Immunol. 94 1993 174 181
44. P. Rutgeerts, K. Goboes, M. Peeters, M. Hiele, F. Penninckx, R. Aerts, R. Kerremans, and G. Vantrappen Effect of fecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum Lancet 338 1991 771 774
45. B. Sadlack, H. Merz, H. Schorle, A. Schimpi, A.C. Feller, and I. Horak Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene Cell 75 1993 253 261
46. R.B. Sartor Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases Am. J. Gastroenterol. 92 1997 55 115
47. M.S. Schultz, S.L. Tonkonogy, R.K. Sellon, C. Veltkamp, V.L. Godfrey, J. Kwon, W.B. Grenther, E. Balish, I. Horak, and R.B. Sartor IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation Am. J. Physiol. 276 1999 G1461 G1472
48. R.K. Sellon, S. Tonkonogy, M. Schultz, L.A. Dieleman, W. Grenther, E. Balish, D.M. Rennick, and R.B. Sartor Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in Interleukin-10-deficient mice Infect. Immun. 66 1998 5224 5231
49. + T cells in an experimental model of colitis Eur. J. Immunol. 27 1997 17 25
50. C. Stevens, C. Walz, M.C. Singara, M.I. Lipman, B. Zanker, and A. Muggia Tumour necrosis factor alpha, interleukin-1B and interleukin-6 expression in inflammatory bowel disease Dig. Dis. Sci. 37 1992 818 826
51. X. Sun, M.S. Caplan, Y. Liu, and W. Hsuch Endotoxin-resistant mice are protected from PAF-induced bowel injury and death Dig. Dis. Sci. 40 1995 495 502
52. L. Sutherland, J. Singleton, and J. Sessions Double-blind, placebo controlled trial of metronidazole in Crohn's disease Gut 32 1991 1071 1075
53. A. Swidsinski, A. Ladhoff, A. Pernthaler, S. Swidsinski, V. Loening-Baucke, M. Ortner, J. Weber, U. Hoffmann, S. Schreiber, M. Dietel, and H. Lochs Mucosal flora in inflammatory bowel disease Gastroenterology 122 2002 44 54
54. M.I. Torres, M. Garcia-Martin, M.I. Fernandez, N. Nieto, A. Gil, and A. Rios Experimental colitis induced by trinitrobenzene sulphonic acid. An ultrastructural and histochemical study Dig. Dis. Sci. 44 1999 2523 2529
55. K.J. Tracey, B. Beutler, S.F. Lowry, J. Merryweather, S. Wolpe, and I.W. Milsark Shock and tissue injury induced by recombinant human cachectin Science 234 1986 470 474
56. J.A.A. Van der Wiel-Korstanje, and K.C. Winkler The focal flora in ulcerative colitis J. Med. Microbiol. 8 1975 491 501
57. H.M. Van Dullemen, S.J. Van Deventer, D.W. Hommes, H.A. Bijl, J. Jansen, G.N. Tytgat, and J. Woody Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2) Gastroenterology 109 1995 129 135
58. S. Videla, J. Vilaseca, F. Guarner, A. Salas, F. Treserra, E. Crespo, M. Antolin, and J.R. Malagelada Role of intestinal microflora in chronic inflammation and ulceration of the rat colon Gut 35 1994 1090 1097
59. H. Von-Wulffen, H. Russman, and H. Karch Verocytotoxin-producing Escherichia coli O2:H5 isolated from patients with ulcerative colitis Lancet I 1989 1449 1450
60. J.L. Wallace Strategies for therapeutic modulation of colitis H. Goebell K. Ewe H. Malchow C. Koebel Inflammatory Bowel Disease. Progress in Basic Research and Clinical Implications 1991 Dordrecht Kluwer 179 189
61. T. Yamada, and M.B. Grisham Pathogenesis of tissue injury: role of reactive metabolites of oxygen and nitrogen S.R. Targan F. Shanahan Inflammatory Bowel Disease From Bench to Bedside 1994 Williams and Wilkins Baltimore, MD 133 150
62. T. Yamada, E. Deitch, R.D. Specian, M.A. Perry, R.B. Sartor, and M.B. Grisham Mechanisms of acute and chronic intestinal inflammation induced by indomethacin Inflammation 17 1993 641 662